Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287287
Status:
COMPLETED
Last Update Posted:
2020-06-12
First Post:
2006-02-03
Brief Title:
REVLIMID Lenalidomide for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Sponsor:
Kenneth Ain
Organization:
University of Kentucky
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
ACTUAL
Primary Completion Date:
2010-07-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07-06
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-03
First Submit QC Date:
February 3 2006
Study First Post Date:
2006-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-06-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-28
Last Update Post Date:
2020-06-12
Last Update Post Date Type:
ACTUAL